AtriCure Inc

ATRC

Company Profile

  • Business description

    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

  • Contact

    7555 Innovation Way
    MasonOH45040
    USA

    T: +1 513 755-4100

    E: [email protected]

    https://www.atricure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    1,350

Stocks News & Analysis

stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed
stocks

The SpaceX IPO and the Elon Musk factor

Potential investors should remember that the company’s controlling shareholder can move markets with a few words.
stocks

The ASX’s most shorted stocks in 2026

What we can and can’t learn from the top 20 most shorted ASX shares.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,657.502.200.03%
CAC 407,772.4570.500.92%
DAX 4022,562.88262.131.18%
Dow JONES (US)45,307.15140.510.31%
FTSE 10010,091.03123.681.24%
HKSE24,750.79201.09-0.81%
NASDAQ20,849.5198.85-0.47%
Nikkei 22551,885.851,487.22-2.79%
NZX 50 Index12,748.92186.47-1.44%
S&P 5006,360.468.39-0.13%
S&P/ASX 2008,461.000.100.00%
SSE Composite Index3,923.299.560.24%

Market Movers